Entasis Therapeutics Holdings Inc.
ETTX
ETTX was delisted on the 8th of July, 2022.
0 hedge funds and large institutions have $0 invested in Entasis Therapeutics Holdings Inc. in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 27 closing their positions.
100% less funds holding
Funds holding: 27 → 0 (-27)
100% less capital invested
Capital invested by funds: $12.5M → $0 (-$12.5M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 27
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GLAM
Gardner Lewis Asset Management
Chadds Ford,
Pennsylvania
|
-$2.75M |
| 2 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$2.49M |
| 3 |
TGA
TPG GP A
Fort Worth,
Texas
|
-$2.25M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.11M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$866K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$2K | -1,000 | Closed |
|
ETTX Hedge Fund Activity: Q3 2022 in Review
0 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Entasis Therapeutics Holdings Inc. (ETTX) for Q3 2022, worth a combined $0 — down 100% from $12.5M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of ETTX and 0 opened new positions — a net loss of 27 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Gardner Lewis Asset Management, exiting entirely with an estimated $2.75M sold.
- 0 institutional investors held Entasis Therapeutics Holdings Inc. (ETTX) as of Q3 2022, down from 27 in Q2 2022.
- Funds reported $0 of Entasis Therapeutics Holdings Inc. stock for Q3 2022, down 100% quarter-over-quarter.
- 0 funds opened new Entasis Therapeutics Holdings Inc. positions in Q3 2022 and 27 closed out, a net change of -27 holders.
- The largest Entasis Therapeutics Holdings Inc. seller in Q3 2022 was Gardner Lewis Asset Management, an estimated $2.75M sold.
Based on aggregated 13F filings for Q3 2022.